TOMI Advances Toward NSF Certification to Address Multi-Billion-Dollar Pharmaceutical, Biotech and Cleanroom Decontamination Markets
Rhea-AI Summary
TOMI (NASDAQ:TOMZ) announced a key step toward NSF certification for its patented SteraMist ionized Hydrogen Peroxide (iHP) decontamination technology. TOMI and partner Total Clean Air are presenting to the NSF Joint Committee on Biosafety Cabinets to define validation studies across multiple biosafety cabinet types.
Management believes NSF certification could support wider SteraMist adoption in pharmaceutical manufacturing, biotechnology, cleanrooms, research labs, and other high-containment facilities, helping address multi‑billion‑dollar contamination‑control markets and potentially expanding TOMI’s addressable market and recurring revenue opportunities.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – TOMZ
On the day this news was published, TOMZ gained 0.29%, reflecting a mild positive market reaction. Argus tracked a peak move of +6.3% during that session. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $53K to the company's valuation, bringing the market cap to $18.19M at that time.
Data tracked by StockTitan Argus on the day of publication.
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 11 | Biosecurity opportunity | Positive | -5.6% | Outlined World Cup-driven biosecurity demand and multi-billion market potential. |
| Jun 08 | AI/robotics strategy | Positive | -2.9% | Detailed plans for drone-enabled SteraMist across AI and autonomous robotics markets. |
| Jun 05 | Outbreak-driven demand | Positive | -3.7% | Highlighted SteraMist demand amid global disease threats and NASA biosecurity use. |
| Jun 04 | EU approvals | Positive | -3.7% | Announced new EU BIT approvals expanding regulatory footprint in Europe. |
| Jun 04 | Food facility install | Positive | +3.9% | Reported SteraMist Hybrid purchase for expanded food facility infrastructure. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive operational and market-expansion updates have often been followed by negative next-day price reactions, with only one of five recent news items aligning positively.
Over the last few weeks, TOMI highlighted multiple growth angles: a World Cup biosecurity opportunity on Jun 11, AI/robotics-enabled deployment on Jun 8, and disease-outbreak-driven demand plus a NASA selection on Jun 5. Earlier in June, it reported European regulatory approvals and a food safety installation on Jun 4. Despite broadly positive themes, four of these five releases saw negative 24-hour price reactions, framing today’s NSF certification progress as part of a continuing effort to expand SteraMist’s addressable markets.
Regulatory & Risk Context
An effective S-3 shelf filed on Nov 14, 2025 registers up to $50,000,000 of securities, giving TOMI flexibility to raise capital over time via equity or other instruments as detailed in prospectus supplements.
Key Terms
ionized hydrogen peroxide medical
biosafety cabinets medical
cleanrooms technical
nsf certification regulatory
decontamination protocol technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Certification process could position SteraMist® as a validated decontamination standard across biosafety cabinets, containment enclosures, cleanrooms, and life sciences facilities worldwide
FREDERICK, Md., June 17, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced a major step toward achieving NSF certification for its patented SteraMist ionized Hydrogen Peroxide (iHP) technology, a milestone that could accelerate adoption across pharmaceutical manufacturing, biotechnology, cleanroom, biosafety, and laboratory markets worldwide.
NSF International is a global, independent organization that develops public health standards and certifications to protect food, water, consumer products, and the environment.
The initiative targets some of the fastest-growing sectors of the global contamination-control industry, including pharmaceutical production facilities, vaccine manufacturing operations, cell and gene therapy laboratories, biomedical research institutions, biosafety cabinets, and high-containment environments. Together, these markets represent billions of dollars in annual spending on contamination prevention, validation, and facility operations.
As part of the certification process, TOMI and its strategic partner, Total Clean Air (TCA), will be presenting today before the NSF Joint Committee on Biosafety Cabinets. The presentation is designed to establish the framework for formal validation studies to test SteraMist iHP decontamination protocol across multiple types of biosafety cabinets (BSCs), that could ultimately lead to NSF certification of TOMI's SteraMist decontamination protocol.
Management believes NSF certification would provide independent third-party validation of SteraMist's effectiveness, repeatability, and material compatibility, helping remove a significant barrier to adoption for highly regulated industries where validated decontamination procedures are critical.
"Achieving NSF certification has the potential to be a transformative milestone for TOMI," said Elissa (E.J.) Shane, COO of TOMI Environmental Solutions. "This process is about much more than biosafety cabinets. It is about positioning SteraMist for broader adoption across pharmaceutical manufacturing, biotechnology, research laboratories, cleanrooms, and other mission-critical environments where contamination control is essential."
The company believes certification could help streamline purchasing decisions for facility operators, biosafety officers, pharmaceutical manufacturers, and equipment providers by providing an independent industry-recognized validation standard. The certification may also facilitate broader relationships with biosafety cabinet manufacturers, cleanroom operators, validation consultants, and life sciences service providers.
The global life sciences industry continues to invest heavily in contamination-control technologies driven by growth in biologics manufacturing, cell and gene therapy production, vaccine development, advanced research, and regulatory compliance requirements. TOMI believes SteraMist's rapid cycle times, broad-spectrum efficacy, and material compatibility position the technology to capitalize on these long-term industry trends.
"Our objective is to establish SteraMist as a trusted decontamination solution across the life sciences ecosystem," Shane added. "NSF certification would represent an important step toward expanding our addressable market, accelerating adoption, and creating new recurring revenue opportunities across multiple high-value industry verticals."
For more information about SteraMist and TOMI Environmental Solutions, visit SteraMist.com.
About TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.
About Total Clean Air Limited (TCA)
Total Clean Air Limited (TCA) is a Somerset-based cleanroom engineering and contamination control specialist. The company provides end-to-end clean air solutions, including the design, engineering, construction, commissioning and validation of cleanrooms and controlled environments for highly regulated industries.
Founded in 2018, the business draws on more than 50 years of combined industry experience and has delivered more than 200 cleanroom projects across the UK and internationally. Total Clean Air works with organisations operating in sectors including pharmaceuticals, biotechnology, aerospace, advanced manufacturing and scientific research.
Total Clean Air is one of only two UKAS ISO 17025-accredited cleanroom constructors in the UK, supporting clients in achieving compliance with ISO, GMP and other globally recognised standards. Headquartered in Street, Somerset, the company serves clients across the UK, Europe and the Middle East.
TCA won the accolade ‘Best Cleanroom Design & Construction Company 2026 – UK’ from Global Health Pharma (GHP) magazine in March 2026 and earned recognition as the Best Cleanroom, Clean Air and Containment Solutions Provider at the Corporate Excellence Awards 2023. Founded in 2018 and headquartered in Somerset, the company remains devoted to innovation, regulatory compliance, and exceptional customer satisfaction.
Forward-Looking Statements
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products and services to serve the life sciences sector. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Zach Nevas
IMS Investor Relations
tomi@imsinvestorrelations.com
